Literature DB >> 25108211

Ion channels and transporters as therapeutic targets in the pulmonary circulation.

Andrea Olschewski1, Rita Papp2, Chandran Nagaraj2, Horst Olschewski3.   

Abstract

Pulmonary circulation is a low pressure, low resistance, high flow system. The low resting vascular tone is maintained by the concerted action of ion channels, exchangers and pumps. Under physiological as well as pathophysiological conditions, they are targets of locally secreted or circulating vasodilators and/or vasoconstrictors, leading to changes in expression or to posttranslational modifications. Both structural changes in the pulmonary arteries and a sustained increase in pulmonary vascular tone result in pulmonary vascular remodeling contributing to morbidity and mortality in pediatric and adult patients. There is increasing evidence demonstrating the pivotal role of ion channels such as K(+) and Cl(-) or transient receptor potential channels in different cell types which are thought to play a key role in vasoconstrictive remodeling. This review focuses on ion channels, exchangers and pumps in the pulmonary circulation and summarizes their putative pathophysiological as well as therapeutic role in pulmonary vascular remodeling. A better understanding of the mechanisms of their actions may allow for the development of new options for attenuating acute and chronic pulmonary vasoconstriction and remodeling treating the devastating disease pulmonary hypertension.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelin receptor antagonists; Ion channels; Prostacyclin; Pulmonary hypertension; Soluble guanylate cyclase stimulators; Sympathetic neurotransmitter

Mesh:

Substances:

Year:  2014        PMID: 25108211     DOI: 10.1016/j.pharmthera.2014.08.001

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  9 in total

1.  Determinants of Ion-Transporter Cancer Cell Death.

Authors:  Sang-Hyun Park; Seong-Hyun Park; Ethan N W Howe; Ji Young Hyun; Li-Jun Chen; Inhong Hwang; Gabriela Vargas-Zuñiga; Nathalie Busschaert; Philip A Gale; Jonathan L Sessler; Injae Shin
Journal:  Chem       Date:  2019-05-20       Impact factor: 22.804

2.  Potassium Channels in the Transition from Fetal to the Neonatal Pulmonary Circulation.

Authors:  Chandran Nagaraj; Yingji Li; Bi Tang; Natalie Bordag; Divya Guntur; Péter Enyedi; Horst Olschewski; Andrea Olschewski
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

3.  Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.

Authors:  Chandran Nagaraj; Bi Tang; Bence M Nagy; Rita Papp; Pritesh P Jain; Leigh M Marsh; Andrea L Meredith; Bahil Ghanim; Walter Klepetko; Grazyna Kwapiszewska; E Kenneth Weir; Horst Olschewski; Andrea Olschewski
Journal:  Eur Respir J       Date:  2016-08-18       Impact factor: 16.671

Review 4.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Authors:  Steven C Pugliese; Jens M Poth; Mehdi A Fini; Andrea Olschewski; Karim C El Kasmi; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

5.  Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease.

Authors:  Na Zhu; Carrie L Welch; Jiayao Wang; Philip M Allen; Claudia Gonzaga-Jauregui; Lijiang Ma; Alejandra K King; Usha Krishnan; Erika B Rosenzweig; D Dunbar Ivy; Eric D Austin; Rizwan Hamid; Michael W Pauciulo; Katie A Lutz; William C Nichols; Jeffrey G Reid; John D Overton; Aris Baras; Frederick E Dewey; Yufeng Shen; Wendy K Chung
Journal:  Genome Med       Date:  2018-07-20       Impact factor: 11.117

Review 6.  Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation.

Authors:  Divya Guntur; Horst Olschewski; Péter Enyedi; Réka Csáki; Andrea Olschewski; Chandran Nagaraj
Journal:  Biomolecules       Date:  2021-11-03

7.  Transmembrane protein 16A/anoctamin 1 inhibitor T16Ainh-A01 reversed monocrotaline-induced rat pulmonary arterial hypertension.

Authors:  Jianye Xie; Wenyuan Liu; Wenjing Lv; Xiaohua Han; Qingnuan Kong; Yuhui Wu; Xin Liu; Ying Han; Chunying Shi; Xiujuan Jia
Journal:  Pulm Circ       Date:  2020-10-26       Impact factor: 3.017

8.  AMP-activated protein kinase inhibits Kv 1.5 channel currents of pulmonary arterial myocytes in response to hypoxia and inhibition of mitochondrial oxidative phosphorylation.

Authors:  Javier Moral-Sanz; Amira D Mahmoud; Fiona A Ross; Jodene Eldstrom; David Fedida; D Grahame Hardie; A Mark Evans
Journal:  J Physiol       Date:  2016-06-30       Impact factor: 5.182

9.  Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension.

Authors:  Csilla Fazakas; Chandran Nagaraj; Diana Zabini; Attila G Végh; Leigh M Marsh; Imola Wilhelm; István A Krizbai; Horst Olschewski; Andrea Olschewski; Zoltán Bálint
Journal:  Front Physiol       Date:  2018-05-15       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.